GlipiZIDE Extended-release Tablets — Class II drug recall D-1276-2019
Terminated recall by American Health Packaging, reported 2019-05-08, distributed nationwide. Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release result
| Recall number | D-1276-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2019-04-08 |
| Classified | 2019-05-10 |
| Reported by FDA | 2019-05-08 |
| Terminated | 2020-11-06 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 68084-0295-21 |
| Lot numbers | 181288 |
| Expiration dates | 2020-05-31 |
Product
GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21
Reason for recall
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1276-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.